---
schema_version: "secwatch.filing_event.v1"
accession: "0001599298-24-000051"
form_type: "8-K"
ticker: "SMMT"
cik: "0001599298"
company_name: "Summit Therapeutics Inc."
filed_at: "2024-04-03T23:59:59+00:00"
generated_at: "2026-06-04T02:51:13.729890+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Summit Therapeutics CFO resigns; COO Manmeet Soni appointed new CFO

## Summary
- CFO Ankur Dhingra resigned April 2, 2024, not due to any disagreement with the company.
- COO Manmeet Soni appointed CFO in addition to his COO role; receives $100K cash bonus and 1,100,000 options vesting over 4 years.
- Bhaskar Anand hired as Chief Accounting Officer, Head of Finance; salary $430K, 40% bonus, 1,200,000 options (half performance-based).
- New CFO Manmeet Soni previously CFO at Reata and Alnylam; both Soni and Anand are CPAs and Chartered Accountants.
- Anand previously served as CAO at Reata and assisted with a $7.5B merger with Biogen.

## SEC filing metadata
- accession: 0001599298-24-000051
- form_type: 8-K
- ticker: SMMT
- cik: 0001599298
- company_name: Summit Therapeutics Inc.
- filed_at: 2024-04-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000051/0001599298-24-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000051/smmt-20240402.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001599298-24-000051
- JSON: https://secwatch.observer/filing/0001599298-24-000051.json
- Plain text: https://secwatch.observer/filing/0001599298-24-000051.txt

## Key facts
- Executive change
  Bhaskar Anand was appointed as Chief Accounting Officer, Head of Finance at Summit Therapeutics Inc..
  - Action: hired
  - Role: Chief Accounting Officer, Head of Finance
  source text: On April 2, 2024, the Company hired Bhaskar Anand as Chief Accounting Officer, Head of Finance, to serve as its principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000051/0001599298-24-000051-index.htm
- Executive change
  Ankur Dhingra resigned as Chief Financial Officer at Summit Therapeutics Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On April 2, 2024, Ankur Dhingra, the principal financial officer and principal accounting officer of Summit Therapeutics Inc. (the “Company”), resigned as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000051/0001599298-24-000051-index.htm
- Executive change
  Manmeet Soni was appointed as Chief Financial Officer at Summit Therapeutics Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the Company appointed its Chief Operating Officer Manmeet Soni to the office of Chief Financial Officer, in which capacity he will serve as the Company’s principal financial officer, in addition to his continuing service as Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000051/0001599298-24-000051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.